You are here

Electrophysiology & Arrhythmia

 

Patients with systolic heart failure who received a novel technology using the SonR hemodynamic sensor were more likely to respond to cardiac resynchronization therapy (CRT) compared with those who used echocardiographic optimization, according to a prospective trial. Patients in the SonR group also had a statistically significant, 35 percent reduction in heart failure-related hospitalizations.

 

 

Recent Headlines

CMS seeks comments on leadless cardiac pacemakers

The Centers for Medicare & Medicaid Services (CMS) announced on May 18 that it was initiating a national coverage analysis for leadless cardiac pacemakers.

Medicare patients experience high rates of complications and reoperations following ICD implantation

An observational cohort study found that Medicare patients had a high rate of device-related complications and reoperations for other causes following implantation with implantable cardioverter-defibrillators (ICDs).

HRS.16: Two physicians receive grants for atrial fibrillation research

Two physicians received a total of $500,000 in grants from the Heart Rhythm Society (HRS) and Boehringer Ingelheim Pharmaceuticals to support quality improvement research on atrial fibrillation and stroke prevention.

HRS.16: S-ICD system is safe for patients at risk for sudden cardiac arrest

After 360 days, 98 percent of patients who were implanted with Boston Scientific’s subcutaneous implantable defibrillator (S-ICD) system were free from complications, according to a multi-national registry.

HRS.16: Hispanics, African Americans with heart failure are at lower risk of developing atrial fibrillation

A retrospective analysis found Hispanic and African American patients with heart failure had a lower risk of developing atrial fibrillation compared with white patients who had heart failure.

HRS.16: Ganglionic plexus ablation leads to worse outcomes in AFib patients

A randomized trial of patients undergoing thoracoscopic surgery for advanced atrial fibrillation found that additional ganglionic plexus ablation was associated with significantly more periprocedural major bleeding, sinus node dysfunction and pacemaker implantation. Patients in the ganglionic plexus ablation group also did not have improvements in rhythm outcomes.

HRS.16: SonR technology helps reduce heart failure hospitalizations by 35%

Patients with systolic heart failure who received a novel technology using the SonR hemodynamic sensor were more likely to respond to cardiac resynchronization therapy (CRT) compared with those who used echocardiographic optimization, according to a prospective trial. Patients in the SonR group also had a statistically significant, 35 percent reduction in heart failure-related hospitalizations.

HRS.16: Patients with atrial fibrillation who receive warfarin have increased risk of dementia

An analysis of patients who received warfarin found the presence of atrial fibrillation significantly increased the risk of dementia. Patients with atrial fibrillation had a significantly higher rate of total dementia, Alzheimer’s disease and vascular dementia compared with patients who had thromboembolism or mechanical heart valves.

FDA approves ICDs for atrial fibrillation

The FDA approved the Visia AF MRI SureScan and Visia AF single-chamber implantable cardioverter defibrillators (ICDs) on May 2 to treat patients with atrial fibrillation.

FDA approves MR-conditional pacing system for patients with bradycardia

The FDA approved the ImageReady MR-conditional pacing system on April 25 to treat patients with bradycardia.

Pages